Sachetta’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08K Sell
119
-129
-52% -$7K ﹤0.01% 649
2026
Q1
$15.6K Sell
248
-24
-9% -$1.92K 0.01% 349
2025
Q4
$25.9K Sell
272
-1,666
-86% -$163K 0.01% 264
2025
Q3
$189K Buy
1,938
+34
+2% +$3.52K 0.07% 149
2025
Q2
$205K Buy
1,904
+31
+2% +$3.14K 0.08% 141
2025
Q1
$189K Buy
1,873
+423
+29% +$42.6K 0.08% 146
2024
Q4
$130K Buy
1,450
+887
+158% +$78.1K 0.05% 180
2024
Q3
$47.2K Sell
563
-55
-9% -$4.34K 0.02% 284
2024
Q2
$45.8K Buy
618
+67
+12% +$4.9K 0.02% 256
2024
Q1
$31.9K Hold
551
0.02% 273
2023
Q4
$31.9K Buy
+551
New +$29.4K 0.02% 273

Other funds holding BSX

Sachetta's BSX Position: Q2 2026 in Review

Sachetta reduced its Boston Scientific (BSX) stake by 52% in Q2 2026, selling an estimated $7K and leaving 119 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Sachetta first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $205K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sachetta held 119 shares of Boston Scientific worth $5.08K as of Q2 2026.
  • Sachetta sold 129 Boston Scientific shares in Q2 2026, an estimated $7K.
  • Boston Scientific made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #649 holding.
  • Sachetta first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Boston Scientific position peaked at $205K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.